Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Summary

Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Chugai Pharmaceutical Co., Ltd. (Chugai or 'the company') is involved in bio pharmaceutical research and development. The company offers medical products and services for the human health. Chugai produces antibody drugs that focus on oncology, renal diseases, immunology and infectious diseases and bone and joint diseases. The company's product portfolio includes Actemra (tocilizumab), Alfarol, Avastin (bevacizumab), Bonviva (ibandronate), CellCept (mycophenolate mofetil), Tamiflu (oseltamivir phosphate), Edirol (eldecalcitol), Mircera (epoetin beta pegol), Kadcyla (trastuzumab emtansine), Kytril, and Mircera (epoetin beta pegol). Chugai operates and markets its products in North America, Europe and Asia. The company is headquartered in Tokyo, Japan.

Scope

• Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis
• An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
• Intelligence on Chugai Pharmaceutical Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

• Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Chugai Pharmaceutical Co., Ltd.'s business structure, strategy and prospects.